Similar articles

• Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.

  Bouckaert J, Berglund J, Schembri M, De Genst E, Cools L, Wuhrer M, Hung CS, Pinkner J, Slättegård R, Zavialov A, Choudhury D, Langermann S, Hultgren SJ, Wyns L, Klemm P, Oscarson S, Knight SD, De Greve H. Bouckaert J, et al. Mol Microbiol. 2005 Jan;55(2):441-55. doi: 10.1111/j.1365-2958.2004.04415.x. Mol Microbiol. 2005. PMID: 15659162
• Antiadhesion therapy for urinary tract infections--a balanced PK/PD profile proved to be key for success.

  Jiang X, Abgottspon D, Kleeb S, Rabbani S, Scharenberg M, Wittwer M, Haug M, Schwardt O, Ernst B. Jiang X, et al. J Med Chem. 2012 May 24;55(10):4700-13. doi: 10.1021/jm300192x. Epub 2012 May 4. J Med Chem. 2012. PMID: 22519985
• The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes.

  Bouckaert J, Mackenzie J, de Paz JL, Chipwaza B, Choudhury D, Zavialov A, Mannerstedt K, Anderson J, Piérard D, Wyns L, Seeberger PH, Oscarson S, De Greve H, Knight SD. Bouckaert J, et al. Mol Microbiol. 2006 Sep;61(6):1556-68. doi: 10.1111/j.1365-2958.2006.05352.x. Epub 2006 Aug 23. Mol Microbiol. 2006. PMID: 16930149 Free PMC article.
• Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.

  Mydock-McGrane LK, Hannan TJ, Janetka JW. Mydock-McGrane LK, et al. Expert Opin Drug Discov. 2017 Jul;12(7):711-731. doi: 10.1080/17460441.2017.1331216. Epub 2017 Jun 2. Expert Opin Drug Discov. 2017. PMID: 28506090 Free PMC article. Review.
• Molecular structure of adhesin domains in Escherichia coli fimbriae.

  Westerlund-Wikström B, Korhonen TK. Westerlund-Wikström B, et al. Int J Med Microbiol. 2005 Oct;295(6-7):479-86. doi: 10.1016/j.ijmm.2005.06.010. Int J Med Microbiol. 2005. PMID: 16238022 Review.